title: Association between coronary heart disease and cancers of the breast, prostate, and colon.
abstract: Coronary heart disease (CHD) and cancers of the breast, prostate, and colon are more common in industrialized countries than in the developing world, and to some degree, these conditions appear to share risk factors. To investigate whether there is an association between these cancers and a prior history of CHD, a hospital-based case-control study was conducted at Columbia-Presbyterian Medical Center in New York. The study was based on 252 breast cancer cases, 256 colorectal cancer cases, and 322 benign surgical controls, all of whom underwent biopsy or surgery between January 1989 and December 1992, and on 319 prostate cancer cases and 189 benign prostatic hypertrophy controls diagnosed between January 1984 and December 1986 (prior to widespread use of prostate-specific antigen screening). Medical records were reviewed on each, focusing on the preoperative anesthesia and surgical clearances. No association was found between a history of CHD and breast or colorectal cancer, but an elevated risk was found for prostate cancer (odds ratio, 2.00; 95% confidence interval, 1.18-3.39), using unconditional logistic regression with adjustment for appropriate confounders. No association was found between cigarette smoking and any of the three cancers. Aspirin use was protective for colorectal cancer (odds ratio, 0.35; 95% confidence interval, 0.17-0.73) but had no association with breast or prostate cancer. The study suggests that individuals with CHD are at elevated risk for prostate cancer but not breast or colorectal cancer. Etiological risk factors associated with CHD should be investigated with regard to prostate cancer. Patients with CHD may represent a high-risk group for prostate cancer and potential future targets for prostate cancer screening interventions.
authors.affiliation: Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
authors.forename: A I
authors.initials: AI
authors.lastname: Neugut
authors.forename: D J
authors.initials: DJ
authors.lastname: Rosenberg
authors.forename: H
authors.initials: H
authors.lastname: Ahsan
authors.forename: J S
authors.initials: JS
authors.lastname: Jacobson
authors.forename: N
authors.initials: N
authors.lastname: Wahid
authors.forename: M
authors.initials: M
authors.lastname: Hagan
authors.forename: M I
authors.initials: MI
authors.lastname: Rahman
authors.forename: Z R
authors.initials: ZR
authors.lastname: Khan
authors.forename: L
authors.initials: L
authors.lastname: Chen
authors.forename: A
authors.initials: A
authors.lastname: Pablos-Mendez
authors.forename: S
authors.initials: S
authors.lastname: Shea
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000209:etiology* / Q000601:surgery; D016022:Case-Control Studies; D003110:Colonic Neoplasms / Q000209:etiology* / Q000601:surgery; D015986:Confounding Factors, Epidemiologic; D003327:Coronary Disease / Q000209:etiology*; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011471:Prostatic Neoplasms / Q000209:etiology* / Q000601:surgery; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin